Atlanta, GA, United States of America

Asheley Chapman

This inventor holds 1 USPTO granted patent. Top assignees: Georgia Tech Research Corporation, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asheley Chapman. Retrieved from https://idiyas.com/inventor/asheley-chapman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asheley Chapman and a Patent for SARS-CoV-2 Detection and Treatment

Introduction

Asheley Chapman is an inventor associated with Atlanta, Georgia. Her patent work addresses methods and compositions for detecting and treating SARS-CoV-2 infection.

Latest Patents

Chapman is listed as an inventor on 1 patent: “Compositions and Methods for the Detection and Treatment of SARS-CoV-2 Virus Infection.” The patent concerns approaches intended to support the detection and treatment of infection caused by the virus.

Career Highlights

Chapman’s patent-related affiliations include the United States of America, as represented by the Secretary of the Department of Health and Human Services, and Georgia Tech Research Corporation. These organizations are associated with the patent record provided.

Collaborations

Chapman’s listed coworker is Mg Finn, who is a woman. Their names appear in connection with the patent information provided.

Conclusion

Asheley Chapman’s recorded invention focuses on SARS-CoV-2 detection and treatment, reflecting work connected with federal health research and Georgia Tech Research Corporation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…